Literature DB >> 2276583

Endrin-induced depletion of glutathione and inhibition of glutathione peroxidase activity in rats.

I T Numan1, M Q Hassan, S J Stohs.   

Abstract

1. Recent studies have shown that endrin induces lipid peroxidation and may produce toxicity through an oxidative stress. We have therefore examined the effect of endrin administration to rats on glutathione content and the activities of glutathione metabolizing enzymes. 2. The oral administration of endrin resulted in dose- and time-dependent decreases in hepatic and renal glutathione content with maximum depletion (90%) occurring in liver at approximately 24 hr post-treatment. 3. Decreases in glutathione content were also observed in lung, brain, spleen and heart. 4. Endrin (4 mg/kg) decreased selenium dependent glutathione peroxidase activity in liver and kidney by 64 and 50%, respectively, while small increases were observed in the activities of glutathione reductase and glutathione S-transferase. 5. The toxicity of endrin may be at least in part related to oxidative tissue damage associated with depletion of glutathione and inhibition of glutathione peroxidase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276583     DOI: 10.1016/0306-3623(90)91008-f

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Endrin-induced increases in hepatic lipid peroxidation, membrane microviscosity, and DNA damage in rats.

Authors:  M Bagchi; E A Hassoun; D Bagchi; S J Stohs
Journal:  Arch Environ Contam Toxicol       Date:  1992-07       Impact factor: 2.804

2.  Acute hexachlorocyclohexane-induced oxidative stress in rat cerebral hemisphere.

Authors:  A Sahoo; G B Chainy
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

3.  A Rare Case of Suicide by Ingestion of Phorate: A Case Report and a Review of the Literature.

Authors:  Angelo Montana; Venerando Rapisarda; Massimiliano Esposito; Francesco Amico; Giuseppe Cocimano; Nunzio Di Nunno; Caterina Ledda; Monica Salerno
Journal:  Healthcare (Basel)       Date:  2021-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.